Another blood clot question

[MummaPI]

I think I will be called in the next few weeks and am anxious about the clot risk (however small) with AZ because I have a strong family history of clots. I'll ring the GP this week to ask whether its considered a risk although its impossible to get through to ours at the moment but wondered if anyone who worked in the vaccination centres had any idea if I would be refused it on those grounds?

What age are you? I suppose in your 40s due to the age being called? I guess they will be looking in your own medical history first rather than your relatives/family, unless there’s something strongly hereditary or under investigation.

45, mother died of a cerebral blood clot and brother nearly died of lungs full of clots due to unknown clotting disease.

From the government’s webpage of advice for clinicians

www.gov.uk/government/publications/covid-19-vaccination-blood-clotting-information-for-healthcare-professionals/information-for-healthcare-professionals-on-blood-clotting-following-covid-19-vaccination#risk-factors-for-developing-this-condition

“ The contra-indications to vaccination with the AZ COVID-19 vaccine include individuals who have a history of other extremely rare immune-mediated syndromes that are characterised by thrombosis in combination with thrombocytopaenia – this includes a previous episode of Heparin-Induced Thrombocytopaenia or the same specific clinical picture in association with anti-phospholipid syndrome.

These individuals may be offered vaccination with an alternative COVID-19 vaccine. A history of thromboses on its own is not a contraindication to the vaccine “

These type of clots are incredibly rare. I think a lot of people are getting very confused about a range of other, much more common clots, which are unrelated.

My brother has the anti-phospholipid syndrome. Thanks for the info.

You’re welcome.

Also this:

“Individuals over 30 years of age with past clotting episodes and those diagnosed with thrombophilia, whether or not they are on long term anti-coagulation, remain at risk of COVID-19 disease and should be vaccinated with any of the available vaccines (provided they are not otherwise contra-indicated). The same consideration applies to those who experience common clotting episodes, without concomitant thrombocytopaenia, after the first dose of AZ vaccine.

The Expert Haematology Panel advise that there is no evidence that individuals with a prior history of thrombosis or known risk factors for thrombosis are more at risk of developing the immune complication reported after the AZ vaccine. Furthermore, for the majority of individuals, the risk of recurrent thrombosis due to COVID-19 infection is far greater than the risk of this syndrome.”